Association between increased mortality rate and antibiotic dose adjustment in intensive care unit patients with renal impairment.
Adult
Aged
Anti-Bacterial Agents
/ administration & dosage
Brazil
Cohort Studies
Critical Care
Dose-Response Relationship, Drug
Female
Glomerular Filtration Rate
Hospital Mortality
Hospitalization
Humans
Intensive Care Units
Length of Stay
Male
Middle Aged
Multivariate Analysis
Prognosis
Renal Insufficiency
/ physiopathology
Retrospective Studies
Treatment Failure
Anti-infective agents
Intensive care units
Mortality
Renal insufficiency
Journal
European journal of clinical pharmacology
ISSN: 1432-1041
Titre abrégé: Eur J Clin Pharmacol
Pays: Germany
ID NLM: 1256165
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
30
07
2018
accepted:
24
09
2018
pubmed:
3
10
2018
medline:
4
4
2019
entrez:
3
10
2018
Statut:
ppublish
Résumé
Adjusting the antibiotic dose based on an estimation of the glomerular filtration rate (eGFR) may result in subdosing, which may actually be significantly more problematic for intensive care unit (ICU) patients than not adjusting the dose. The aim of this study was to assess the outcomes of antibiotic dose adjustment in ICU patients with renal impairment. A retrospective cohort study was conducted in adult patients admitted to an ICU of a Brazilian hospital from January 2014 to December 2015. The eGFR was determined using Cockcroft-Gault and Modified Diet in Renal Disease equations for each day of hospitalization. Treatment failure was defined based on the clinical, laboratory, and radiological criteria. A total of 126 patients were assessed to meet the inclusion criteria and subsequently enrolled in the study (19.9% of patients admitted to the ICU during the study period). Of the 168 opportunities for dose adjustment, 99 (58.9%) adjustments were made. The mean eGFR in the group with dose adjustment was lower than that in the group without dose adjustment (38.5 vs. 40.7 mL/min/1.73 m In ICU patients with renal impairment, adjustments in antibiotic dose based on eGFR, significantly increased the risk of treatment failure and death.
Identifiants
pubmed: 30276417
doi: 10.1007/s00228-018-2565-7
pii: 10.1007/s00228-018-2565-7
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
119-126Références
Nephron. 1976;16(1):31-41
pubmed: 1244564
Ann Intern Med. 2006 Aug 15;145(4):247-54
pubmed: 16908915
Crit Care Med. 2009 Mar;37(3):840-51; quiz 859
pubmed: 19237886
Int J Antimicrob Agents. 2009 Aug;34 Suppl 3:S14-9
pubmed: 19596109
Rev Bras Anestesiol. 2010 Jan-Feb;60(1):20-31
pubmed: 20169260
Intern Med J. 2011 Jul;41(7):537-43
pubmed: 21762334
Ann Pharmacother. 2013 Jul-Aug;47(7-8):1039-44
pubmed: 23757387
BMC Geriatr. 2013 Sep 10;13:92
pubmed: 24020893
PLoS One. 2014 Apr 22;9(4):e95991
pubmed: 24755778
Invest New Drugs. 2014 Oct;32(5):913-27
pubmed: 24788562
Drugs Aging. 2014 Jul;31(7):493-9
pubmed: 24902935
Intern Med J. 2014 Jun;44(6):591-6
pubmed: 24946814
J Intensive Care. 2014 May 07;2(1):31
pubmed: 25520843
Int J Environ Res Public Health. 2015 Sep 09;12(9):11227-40
pubmed: 26371029
Expert Opin Drug Saf. 2016 May;15(5):667-78
pubmed: 26961691
Expert Rev Clin Pharmacol. 2016 Jul;9(7):961-79
pubmed: 27018631
Crit Care. 2016 Apr 04;20:79
pubmed: 27039986
Clin Microbiol Infect. 2016 Jul;22(7):625-31
pubmed: 27145210
Clin Pharmacokinet. 2017 Feb;56(2):193-205
pubmed: 27417226
Eur J Clin Pharmacol. 2016 Dec;72(12):1433-1439
pubmed: 27568310
BMC Nephrol. 2017 Jan 17;18(1):26
pubmed: 28095816
Clin Infect Dis. 2017 Aug 15;65(4):644-652
pubmed: 28472416
An Sist Sanit Navar. 2017 Apr 30;40(1):119-130
pubmed: 28534544
J Clin Diagn Res. 2017 May;11(5):BC09-BC12
pubmed: 28658750
J Microbiol Immunol Infect. 2018 Dec;51(6):763-769
pubmed: 28716359
Ther Drug Monit. 2017 Dec;39(6):604-613
pubmed: 29084032
J Antimicrob Chemother. 2018 Mar 1;73(3):564-568
pubmed: 29216348